Nirman Agri Genetics
Nirman Agri Genetics (NIRMAN) share price was ₹22.90 at the 28 Oct 2026 close; market capitalisation ₹18.34 Cr; P/E (TTM) 0.68; sector FMCG. The share price fell 79.3% over the year to 28 Oct 2026 (adjusted for splits and bonuses). In the Mar 2026 quarter, revenue fell 59.7% year on year to ₹50 Cr and net profit was ₹3 Cr, against ₹14 Cr a year earlier (compared with Mar 2025). Promoters held 44.34% of Nirman Agri Genetics in Sep 2026, unchanged from Mar 2026. Its Tapetide Score is 53/100 (Average) as of 28 Oct 2026.
Key Fundamentals
SMEConsumer GoodsFMCGPrice-based figures as of 29 Oct 2026, 10:53 IST · TTM
Peer Comparison
Fast Moving Consumer Goods › FMCG › Agricultural Products › Other Agricultural Products
| ₹379.10 | 20.56 | 13,164 Cr | 2.69 | 0.77% | 13.83% | 18.52% | 12,166 Cr | 640 Cr | |
| ₹350.45 | 10.58 | 8,021 Cr | 1.38 | 1.26% | 11.16% | 14.81% | 6,137 Cr | 758 Cr | |
| ₹143.82 | 15.86 | 6,597 Cr | 1.84 | 0.21% | 9.23% | 12.46% | 6,110 Cr | 416 Cr | |
| ₹685.20 | 14.12 | 3,525 Cr | 1.74 | 0.73% | 16.86% | 17.00% | 1,302 Cr | 249 Cr | |
| ₹375.65 | 20.61 | 3,221 Cr | 1.99 | 0.00% | 6.14% | 10.77% | 2,823 Cr | 159 Cr | |
| ₹91.56 | 23.48 | 1,897 Cr | 3.16 | 0.51% | 12.56% | 20.24% | 1,899 Cr | 77 Cr | |
| ₹27.45 | 0.82 | 22 Cr | 0.17 | 8.68% | 13.80% | 14.23% | 237 Cr | 25 Cr | |
| Median 7 companies | ₹350.45 | 15.86 | 3,525 Cr | 1.84 | 0.73% | 12.56% | 14.81% | 2,823 Cr | 249 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company. 1 company is not shown because they are not listed on an exchange we cover.
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Data confidence 98/100
Category scores
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
Strengths
5- Company has reduced debt.
- Company is almost debt free.
- Stock is trading at 0.16 times its book value
- Company is expected to give good quarter
- Company has delivered good profit growth of 223% CAGR over last 5 years
Weaknesses
5- Though the company is reporting repeated profits, it is not paying out dividend
- Tax rate seems low
- Debtor days have increased from 84.6 to 129 days.
- Promoter holding has decreased over last 3 years: -21.7%
- Working capital days have increased from 133 days to 213 days
Technical Indicators
Oscillators
Bullish
Overall
Bearish
Moving Averages
Bearish
Growth Rate
change over 1 year
change over 1 year
change over 1 year
change over 1 year Operating margin 7% · Mar 2026
Quarterly Results
| Particulars | Mar 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 6 | 14 | 24 | 39 | 112 | 124 | 146 | 50 |
| Expenses | 4 | 11 | 20 | 33 | 100 | 110 | 131 | 47 |
| Operating Profit | 2 | 3 | 4 | 7 | 12 | 15 | 15 | 4 |
| OPM % | 27% | 20% | 19% | 17% | 11% | 12% | 10% | 7% |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
| PBT | 2 | 3 | 4 | 7 | 12 | 14 | 15 | 3 |
| Tax % | 0% | 10% | 10% | 2% | 4% | 3% | 3% | 3% |
| Net Profit | 2 | 2 | 4 | 6 | 11 | 14 | 15 | 3 |
| EPS (₹) | — | 2.96 | 4.91 | 8.1 | 14.3 | 17.04 | 18.2 | 3.78 |
Profit & Loss
| Particulars | Mar 2021 8m | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Sales | 4 | 13 | 29 | 63 | 237 | 197 |
| Expenses | 4 | 10 | 24 | 52 | 210 | 178 |
| Operating Profit | 0 | 3 | 4 | 11 | 27 | 19 |
| OPM % | 1.8% | 25% | 15% | 18% | 11% | 10% |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 1 | 1 |
| PBT | 0 | 3 | 4 | 11 | 26 | 18 |
| Tax % | 29% | 25% | 6% | 5% | 3% | 3% |
| Net Profit | 0 | 3 | 4 | 10 | 25 | 18 |
| EPS (₹) | — | — | 5.01 | 13 | 31.57 | 21.99 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 0% |
Balance Sheet
| Particulars | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Equity Capital | 0.01 | 0.01 | 6 | 6 | 8 | 8 |
| Reserves | 0 | 3 | 21 | 31 | 102 | 120 |
| Borrowings | 1 | 1 | 1 | 1 | 0 | 0 |
| Other Liabilities | 1 | 2 | 2 | 6 | 3 | 2 |
| Total Liabilities | 2 | 6 | 30 | 44 | 113 | 129 |
| Fixed Assets | 0 | 0 | 1 | 0 | 2 | 2 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 2 | 6 | 29 | 44 | 111 | 128 |
| Total Assets | 2 | 6 | 30 | 44 | 113 | 129 |
Cash Flow
| Particulars | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Operating | 0 | 0 | 0 | 4 | -32 | -24 |
| Investing | 0 | 0 | -21 | -2 | 10 | 0 |
| Financing | 1 | 0 | 20 | -1 | 46 | -1 |
| Net Cash Flow | 1 | 0 | -1 | 1 | 24 | -25 |
| Free Cash Flow | 0 | 0 | -1 | 4 | -33 | -25 |
| CFO/EBITDA | -357 | 25 | 2 | 36 | -119 | -130 |
Ratios
| Particulars | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Debtor Days | 58 | 114 | 52 | 67 | 58 | 129 |
| Inventory Days | 21 | 25 | 76 | 61 | — | — |
| Days Payable | 40 | 38 | 6 | 39 | — | — |
| Cash Conversion Cycle | 39 | 101 | 121 | 89 | 58 | 129 |
| Working Capital Days | 32 | 76 | 87 | 76 | 110 | 213 |
| ROCE % | — | 133% | 27% | 34% | 35% | 15% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Nirman Agri Genetics insights
54 extracted metrics + investor summaries across FY21–FY26.
Documents
Frequently Asked Questions about Nirman Agri Genetics
What does Nirman Agri Genetics Ltd do?
Where is Nirman Agri Genetics Ltd (NIRMAN) listed?
Which sector does Nirman Agri Genetics Ltd belong to?
What is the market capitalisation of Nirman Agri Genetics Ltd?
What is the PE ratio of Nirman Agri Genetics Ltd?
What is the 52-week high and low of Nirman Agri Genetics Ltd?
Does Nirman Agri Genetics Ltd pay dividends?
What is the Return on Equity (ROE) of Nirman Agri Genetics Ltd?
Company Information
Incorporated in 2020, Nirman Agri Genetics Ltd is in the business of manufacturing and processing seeds[1]
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/NIRMAN.md for Nirman Agri Genetics Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.